Abstract
Robust, comprehensive assessment of cardiomyocyte morphology is essential from research and clinical perspectives, but current methods predominantly rely on only limited parameters. Addressing this, Furkel et al. present, "C-MORE: A high content single cell morphology assay for cardiovascular medicine" in this issue of Cell Reports Medicine.